Hepato-cardiac disorders

Yasser Mahrous Fouad1, Reem Yehia1

  • 1Yasser Mahrous Fouad, Reem Yehia, Gastroenterology and Hepatology Unit, Endemic Medicine Department, Minia University, Minia 19111, Egypt.

Insights

This review explores hepato-cardiac diseases, where heart conditions impact the liver and vice-versa. Understanding this connection is crucial for diagnosing and managing conditions affecting both organs.

Area of Science:

  • Cardiology
  • Hepatology
  • Internal Medicine

Background:

  • The interplay between liver and heart health is clinically significant for specialists in both fields.
  • Hepato-cardiac diseases encompass conditions where the heart affects the liver, the liver affects the heart, or both organs are simultaneously impacted.
  • Accurate diagnosis of liver injury is vital in cardiology, necessitating collaboration to differentiate from conditions mimicking hemodynamic compromise.

Purpose of the Study:

  • To review the spectrum of hepato-cardiac diseases.
  • To highlight the diagnostic challenges and collaborative needs between cardiologists and hepatologists.
  • To discuss the impact of cardiac conditions on the liver and vice versa, including systemic diseases affecting both.

Main Methods:

  • Literature review of hepato-cardiac diseases.
  • Classification of conditions based on organ involvement (heart-to-liver, liver-to-heart, simultaneous).
  • Discussion of clinical implications, diagnostic considerations, and management strategies.

Main Results:

  • Heart failure can cause ischemic hepatitis or congestive hepatopathy, requiring management of the primary cardiac issue.
  • Advanced liver disease may lead to cirrhotic cardiomyopathy, characterized by hemodynamic and functional cardiac alterations.
  • Liver transplantation can reverse cardiac dysfunction in patients with end-stage liver disease.

Conclusions:

  • Effective management of hepato-cardiac conditions requires a multidisciplinary approach.
  • Cardiac evaluation is essential for patients with liver disease, particularly around liver transplantation.
  • Systemic diseases, including congenital, metabolic, inflammatory conditions, and alcoholism, represent significant etiological factors for concurrent heart and liver disease.

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.2K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
50
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753